undamentalytics Newsletter
Sign in

Zoetis income statement

In fiscal 2025, Zoetis reported revenue of $9.47bn, up 2.3% on the year before and net income of $2.67bn, or $6.02 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue4,2334,3364,5614,7854,7654,8885,3075,8256,2606,6757,7768,0808,5449,2569,4679,517
Cost of revenue1,6521,5631,6691,7171,7381,6661,7751,9111,9922,0572,3032,4542,5612,7192,6662,709
Gross profit2,5812,7732,8923,0683,0273,2223,5323,9144,2684,6185,4735,6265,9836,5376,8016,808
Research and development427409399396364376382432457463508539614686698722
Selling, general and administrative1,4531,4701,6131,6431,5321,3641,3341,4841,6381,7262,0012,0092,1512,3182,3782,378
Interest expense3631113117124166175206223231224221239225222238
Income before tax3947106908205451,2281,5251,6901,8011,9962,4882,6562,9363,1333,3603,272
Income tax146274187233206409663266301360454545596637687656
Net income2454365045833398218641,4281,5001,6382,0372,1142,3442,4862,6732,616
Diluted EPS$0.49$0.87$1.01$1.16$0.68$1.65$1.75$2.93$3.11$3.42$4.27$4.49$5.07$5.47$6.02$6.08
Diluted shares (average)500m500m500m502m502m498m493m487m482m479m477m470m462m455m444m430m

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BHC vs ZTSHLN vs ZTSVTRS vs ZTSOGN vs ZTS

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Zoetis's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Zoetis.